United Arab EmiratesMarket Entry & Growth in United Arab Emirates
The UAE is the Middle East's premier life-sciences hub, offering a streamlined MOHAP regulatory framework and unrivalled access to GCC markets. Taevas delivers end-to-end market entry support so your brand reaches UAE patients and professionals faster.
Four Industries. One United Arab Emirates Team.
Select an industry to see regulatory pathways, services, and how Taevas supports your United Arab Emirates market entry.
Medical Devices & Equipment
Ministry of Health and Prevention (MOHAP) — Medical Devices Department
The UAE medical devices market is valued at over $1.2 billion and is growing rapidly, driven by world-class hospital infrastructure in Dubai and Abu Dhabi. MOHAP mandates device registration under a risk-based classification system ranging from Class A (low risk) to Class D (high risk), with import licences required for all regulated products. Taevas provides full regulatory dossier preparation, local authorised representative services, and post-market surveillance support to ensure your devices reach UAE clinicians without delay.
Regulatory Pathways
Device Registration (MOHAP)
All medical devices must be registered with MOHAP prior to importation or sale. Taevas prepares and submits the complete technical dossier aligned with IMDRF and UAE-specific requirements.
Risk Classification Review
Devices are classified into Classes A through D based on intended use and risk profile. Taevas conducts pre-submission classification assessments to determine the correct pathway and documentation scope.
Import Licence & Customs Clearance
A valid MOHAP import licence is required before any shipment enters UAE ports. Taevas manages the full import licence application and coordinates with UAE Customs authorities for seamless clearance.
Post-Market Surveillance
MOHAP requires ongoing adverse event reporting and periodic safety update submissions for registered devices. Taevas maintains your UAE vigilance programme and liaises with MOHAP on any regulatory queries.
Our Services for Medical Devices in United Arab Emirates
Why Global Brands Choose Taevas for United Arab Emirates
Taevas combines deep MOHAP regulatory expertise with established UAE distributor and KOL networks, giving life-sciences brands the local intelligence and operational infrastructure needed to move from registration to revenue in the UAE.
MOHAP Regulatory Expertise
Our UAE regulatory team has hands-on experience with MOHAP submissions across medical devices, pharmaceuticals, cosmetics, and food supplements, ensuring your dossiers meet current requirements from day one.
GCC Market Gateway
The UAE serves as the strategic entry point for the entire Gulf Cooperation Council. Taevas leverages UAE registrations and logistics infrastructure to accelerate your expansion into Saudi Arabia, Qatar, Kuwait, and beyond.
Accelerated Time to Market
Our pre-submission consultation and dossier quality review processes reduce first-round deficiency letters, cutting typical UAE registration timelines by weeks and getting your products to market faster.
Established Distributor Network
Taevas has cultivated relationships with vetted UAE distributors across hospital, pharmacy, retail, and e-commerce channels, enabling rapid commercial deployment once your products are registered.
KOL and Clinical Networks
We maintain active relationships with leading UAE clinicians, pharmacists, and healthcare decision-makers across DHA, SEHA, and private hospital networks, supporting clinical adoption and brand credibility.
Proven UAE Track Record
Taevas has supported multiple international life-sciences brands through successful UAE market entry, from initial regulatory strategy through to commercial scale-up across all seven emirates.
Ready to Enter the United Arab Emirates Market?
Speak with a Taevas UAE specialist today to map your regulatory pathway, identify the right distribution partners, and build a clear timeline from registration to first sale.